Specialty of Addiction Medicine, Central Clinical School, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
The Edith Collins Centre (Translational Research in Alcohol, Drugs and Toxicology), Sydney Local Health District, Sydney, NSW, Australia.
Womens Health (Lond). 2023 Jan-Dec;19:17455057231200133. doi: 10.1177/17455057231200133.
Women experiencing substance use disorders face barriers to treatment, including childcare, stigma and lack of gender/trauma-informed programming. Several non-government organizations in New South Wales run women-only treatment services to address these needs.
We aim to assess characteristics of women entering treatment in these services.
Data on client characteristics from six women-only non-government organization substance use disorder treatment services in New South Wales between 2014 and 2018 were extracted from a database containing demographics, drug use and treatment characteristics and psychological distress (Kessler-10 scale) of women entering the services. Logistic regression models were used to estimate unadjusted odds ratio and adjusted odds ratio for treatment completion and different drugs on entry.
Data were available for 1357 women. Most (91%) episodes were for residential treatment. Women's mean age was 35.4 years (standard deviation = 9.8; range = 17-67). Residential clients tended to be younger than non-residential clients (35.1 vs 38.5 years, p < 0.001). Methamphetamine (43%) and alcohol (32%) were the most reported principal drug of concern. Women (89%) reported high levels of psychological distress (median Kessler-10 scale score = 27.5, range = 10-50), highest for women reporting alcohol as their principal drug. Overall, 43% of episodes resulted in treatment completion, most commonly for women entering residential treatment (45% vs 22%, p < 0.001) and for alcohol treatment (adjusted odds ratio = 1.42; confidence interval = 1.07-1.90; p < 0.001). Women with Kessler-10 scale scores indicating anxiety or depression at treatment entry were less likely to complete treatment than those with lower scores (adjusted odds ratio = 0.56; confidence interval = 0.38-0.80; p < 0.001).
Women entering women-only residential treatment tend to be younger and report methamphetamine as principal drug of concern. Women enter treatment with high degrees of psychological distress. Women's services need to ensure their programmes can respond to diverse needs of younger women presenting with methamphetamine use disorder and older women with alcohol use disorder experiencing high levels of psychological distress.
患有物质使用障碍的女性在治疗上面临障碍,包括儿童保育、污名化和缺乏性别/创伤知情的治疗方案。新南威尔士州的几个非政府组织开办了仅限女性参加的治疗服务,以满足这些需求。
我们旨在评估这些服务中接受治疗的女性的特征。
从一个包含女性进入服务的人口统计学、药物使用和治疗特征以及心理困扰(Kessler-10 量表)的数据库中提取了新南威尔士州六家仅限女性的非政府组织物质使用障碍治疗服务在 2014 年至 2018 年间接受治疗的女性特征的数据。使用逻辑回归模型估计治疗完成率和不同药物的未调整优势比和调整优势比。
共有 1357 名女性的数据可用。大多数(91%)为住院治疗。女性的平均年龄为 35.4 岁(标准差=9.8;范围=17-67)。住院患者的年龄往往比非住院患者年轻(35.1 岁与 38.5 岁,p<0.001)。最常报告的主要关注药物是甲基苯丙胺(43%)和酒精(32%)。女性(89%)报告有较高的心理困扰(中位数 Kessler-10 量表评分为 27.5,范围为 10-50),报告酒精为主要药物的女性最高。总体而言,43%的病例治疗完成,最常见于接受住院治疗的女性(45%与 22%,p<0.001)和酒精治疗(调整后的优势比=1.42;置信区间=1.07-1.90;p<0.001)。在治疗开始时 Kessler-10 量表评分表明有焦虑或抑郁的女性完成治疗的可能性低于评分较低的女性(调整后的优势比=0.56;置信区间=0.38-0.80;p<0.001)。
进入仅限女性的住院治疗的女性往往更年轻,报告甲基苯丙胺为主要关注药物。女性在接受治疗时心理困扰程度较高。女性服务机构需要确保其方案能够满足年轻女性出现甲基苯丙胺使用障碍和年长女性出现酒精使用障碍且心理困扰程度较高的不同需求。